Sarah Gorrell Kulkarni
Overview
Explore the profile of Sarah Gorrell Kulkarni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
355
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Parcesepe A, Tymejczyk O, Remien R, Gadisa T, Kulkarni S, Hoffman S, et al.
AIDS Care
. 2017 Aug;
30(3):338-342.
PMID: 28820273
HIV diagnosis may be a source of psychological distress. Late initiation of antiretroviral therapy (ART) and treatment-related beliefs may intensify psychological distress among those recently diagnosed. This analysis describes the...
12.
Parcesepe A, Tymejczyk O, Remien R, Gadisa T, Kulkarni S, Hoffman S, et al.
AIDS Care
. 2017 Aug;
30(2):211-218.
PMID: 28774191
Low decision-making power (DMP) has been associated with HIV seropositivity among women in sub-Saharan Africa. As treatment accessibility and life expectancy for HIV-positive individuals increase, greater attention to the mental...
13.
Nash D, Tymejczyk O, Gadisa T, Kulkarni S, Hoffman S, Yigzaw M, et al.
J Int AIDS Soc
. 2016 Apr;
19(1):20637.
PMID: 27113335
Introduction: Most HIV-positive persons in sub-Saharan Africa initiate antiretroviral therapy (ART) with advanced infection (late ART initiation). Intervening on the drivers of late ART initiation is a critical step towards...
14.
Gadisa T, Tymejczyk O, Kulkarni S, Hoffman S, Lahuerta M, Remien R, et al.
AIDS Behav
. 2016 Jan;
21(1):70-81.
PMID: 26781869
HIV status disclosure can help patients obtain support which may influence treatment adherence and subsequent healthcare needs. We examined the extent of disclosure and correlates of non-disclosure among 1180 adults...
15.
Tymejczyk O, Hoffman S, Kulkarni S, Gadisa T, Lahuerta M, Remien R, et al.
AIDS Behav
. 2015 Sep;
20(5):998-1008.
PMID: 26346333
To better understand patient beliefs, which may influence adherence to HIV care and treatment, we examined three dimensions of beliefs among Ethiopian adults (n = 1177) initiating antiretroviral therapy (ART)....
16.
Hoffman S, Wu Y, Lahuerta M, Kulkarni S, Nuwagaba-Biribonwoha H, El Sadr W, et al.
AIDS
. 2014 Aug;
28(16):2429-38.
PMID: 25136842
Objectives: To examine changes between 2006 and 2011 in the proportion of HIV-positive patients newly enrolled in HIV care with advanced disease and the median CD4 cell count at enrollment;...
17.
Lahuerta M, Wu Y, Hoffman S, Elul B, Kulkarni S, Remien R, et al.
Clin Infect Dis
. 2013 Nov;
58(3):432-41.
PMID: 24198226
Background: Timely antiretroviral therapy (ART) initiation requires early diagnosis of human immunodeficiency virus (HIV) infection with prompt enrollment and engagement in HIV care. Methods: We examined programmatic data on 334...
18.
Lahuerta M, Ue F, Hoffman S, Elul B, Kulkarni S, Wu Y, et al.
J Health Care Poor Underserved
. 2013 Feb;
24(1):359-83.
PMID: 23377739
Efforts to scale-up HIV care and treatment have been successful at initiating large numbers of patients onto antiretroviral therapy (ART), although persistent challenges remain to optimizing scale-up effectiveness in both...